BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23108406)

  • 1. A tumor suppressor role for srGAP3 in mammary epithelial cells.
    Lahoz A; Hall A
    Oncogene; 2013 Oct; 32(40):4854-60. PubMed ID: 23108406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors.
    Montanari M; Boninsegna A; Faraglia B; Coco C; Giordano A; Cittadini A; Sgambato A
    J Cell Physiol; 2005 Jan; 202(1):215-22. PubMed ID: 15389519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
    Sivko GS; DeWille JW
    J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase 6 inhibits proliferation of human mammary epithelial cells.
    Lucas JJ; Domenico J; Gelfand EW
    Mol Cancer Res; 2004 Feb; 2(2):105-14. PubMed ID: 14985467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SrGAP3 interacts with lamellipodin at the cell membrane and regulates Rac-dependent cellular protrusions.
    Endris V; Haussmann L; Buss E; Bacon C; Bartsch D; Rappold G
    J Cell Sci; 2011 Dec; 124(Pt 23):3941-55. PubMed ID: 22159416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular function of srGAP3 and its role in neuronal morphogenesis.
    Bacon C; Endris V; Rappold GA
    Mech Dev; 2013; 130(6-8):391-5. PubMed ID: 23127797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
    Sultan AS; Brim H; Sherif ZA
    Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells.
    Chen J; Miller EM; Gallo KA
    Oncogene; 2010 Aug; 29(31):4399-411. PubMed ID: 20514022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of p27Kip1 inhibits the growth of both normal and transformed human mammary epithelial cells.
    Sgambato A; Zhang YJ; Ciaparrone M; Soh JW; Cittadini A; Santella RM; Weinstein IB
    Cancer Res; 1998 Aug; 58(15):3448-54. PubMed ID: 9699679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROCK signaling mediates the adoption of different modes of migration and invasion in human mammary epithelial tumor cells.
    Torka R; Thuma F; Herzog V; Kirfel G
    Exp Cell Res; 2006 Nov; 312(19):3857-71. PubMed ID: 17010335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of PSF1 promotes the growth of breast cancer cells.
    Nakahara I; Miyamoto M; Shibata T; Akashi-Tanaka S; Kinoshita T; Mogushi K; Oda K; Ueno M; Takakura N; Mizushima H; Tanaka H; Ohta T
    Genes Cells; 2010 Oct; 15(10):1015-24. PubMed ID: 20825491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
    Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
    Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells.
    Jia Y; Zeng ZZ; Markwart SM; Rockwood KF; Ignatoski KM; Ethier SP; Livant DL
    Cancer Res; 2004 Dec; 64(23):8674-81. PubMed ID: 15574776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.
    Duss S; André S; Nicoulaz AL; Fiche M; Bonnefoi H; Brisken C; Iggo RD
    Breast Cancer Res; 2007; 9(3):R38. PubMed ID: 17573968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
    Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
    Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
    Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
    Travaglini L; Vian L; Billi M; Grignani F; Nervi C
    Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.
    Aydoğdu E; Katchy A; Tsouko E; Lin CY; Haldosén LA; Helguero L; Williams C
    Carcinogenesis; 2012 Aug; 33(8):1502-11. PubMed ID: 22562546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.